The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of the Lung Cancer Mutation Consortium LCMC4 evaluation of actionable drivers in early stage lung cancer (LEADER) screening trial.
 
Jamie E. Chaft
Consulting or Advisory Role - Arcus Biosciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Flame Biosciences; Genentech/Roche; Guardant Health; Janssen Oncology; Lilly; Merck; Sanofi/Regeneron
Research Funding - AstraZeneca/MedImmune (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Scott Swanson
No Relationships to Disclose
 
Jay M. Lee
Stock and Other Ownership Interests - Moderna Therapeutics
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; Foundation Medicine; Genentech/Roche; Merck; Novartis; Regeneron
Speakers' Bureau - AstraZeneca; Genentech/Roche
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Novartis
Patents, Royalties, Other Intellectual Property - UCLA Patents
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche
(OPTIONAL) Uncompensated Relationships - Genentech/Roche; Novartis
 
Jules Lin
Consulting or Advisory Role - Intuitive Surgical
Research Funding - Genentech (Inst); Novartis (Inst)
 
Hisashi Tsukada
No Relationships to Disclose
 
Tianhong Li
Consulting or Advisory Role - Bristol Myers Squibb; Janssen
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Chugai Pharma USA (Inst); Duality Biologics (Inst); Genentech (Inst); Jounce Therapeutics (Inst); LabyRx Immuno-Oncology (Inst); Lung Cancer Mutation Consortium (Inst); Merck (Inst); Novartis (Inst); Nvigen (Inst); OncoImmune/OncoC4 (Inst); RasCal (Inst); Tempus (Inst); Xilio Therapeutics (Inst)
 
R. Taylor Ripley
Speakers' Bureau - Merck
Research Funding - AstraZeneca (Inst)
Expert Testimony - Dean Omar Branham Shirley
Other Relationship - NCI, NIH funding (Inst)
 
Jussuf T. Kaifi
Stock and Other Ownership Interests - Extract Biologics LLC
Patents, Royalties, Other Intellectual Property - extract biologics (Inst); extract bioloics
 
Christina S Baik
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo/UCB Japan; Genentech/Roche; Janssen; Pfizer
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Lilly (Inst); Loxo (Inst); Nuvalent, Inc. (Inst); Pfizer (Inst); Rain Therapeutics (Inst); Spectrum Pharmaceuticals (Inst); TP Therapeutics (Inst)
 
Paul A. Bunn
Leadership - Verastem
Honoraria - Ascentage Pharma; AstraZeneca; BMS; CStone Pharmaceuticals; Imedex; Lilly/ImClone; Merck; Viecure
Consulting or Advisory Role - Ascentage Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; CStone Pharmaceuticals; Genentech/Roche; Imedex; Imedex; Merck; viecure
Travel, Accommodations, Expenses - Verastem
 
Candice Francheska Tambaoan
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Foundation Medicine
 
Richard S.P. Huang
Employment - Roche/Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Patent on IHC; provisional patent on biomarkers and biomarker methodology.
 
David R Jones
Consulting or Advisory Role - AstraZeneca; More Health
Speakers' Bureau - DAVA Oncology; Genentech/Roche
Expert Testimony - MGH Hospitals
Travel, Accommodations, Expenses - DAVA Oncology
(OPTIONAL) Uncompensated Relationships - Merck
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; BerGenBio; Daiichi Sankyo/Astra Zeneca; Merus; Mirati Therapeutics; Pfizer; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Genentech